Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$456.95 USD
+6.15 (1.36%)
Updated May 24, 2024 04:00 PM ET
After-Market: $457.02 +0.07 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Earnings News For VRTX
-
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
-
Vertex: Q1 Earnings Snapshot
-
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
-
Vertex Reports First Quarter 2024 Financial Results
-
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
-
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
-
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
-
Vertex (VRTX) Down 0.2% Since Last Earnings Report: Can It Rebound?
-
Vertex's (VRTX) Q4 Earnings and Sales Surpass Estimates
-
Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates
-
Vertex: Q4 Earnings Snapshot
-
Vertex: Q4 Earnings Snapshot
-
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
-
Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?
-
Why Is Vertex (VRTX) Down 6.4% Since Last Earnings Report?
-
Vertex (VRTX) Q3 Earnings Beat, Sales Miss, Raises '23 View
-
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings Estimates
-
Vertex: Q3 Earnings Snapshot
-
Vertex Reports Third Quarter 2023 Financial Results
-
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy?
-
Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?
-
Vertex (VRTX) Down 2.1% Since Last Earnings Report: Can It Rebound?
-
Vertex (VRTX) Beats on Q2 Earnings & Sales, Raises '23 View
-
Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Top Estimates
-
Vertex: Q2 Earnings Snapshot